Cleara Biotech
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $2.5M
Investors
- 4
About Cleara Biotech
V. provides therapies for the treatment of different types of “senescent” cells. The company was spun out from the Medical Center Utrecht (UMCU). The company develops the next generation of subtype-specific anti-senescence compounds which helps in restoring tissue homeostasis. Additionally, the firm offers a FOXO4-based treatment approach that uses the biomarker and eliminates the biomarker-positive scarred cells. It develops the technology against scarred cellular senescence which helps in the treatment of metastatic, mutant-p53 cancer.
Who invested in Cleara Biotech
4 investors across 1 round
See all investors in Cleara Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 1, 2022
Amount
$2.5M
Investors
Questions about Cleara Biotech
Who invested in Cleara Biotech?
Cleara Biotech has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cleara Biotech raised?
Cleara Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cleara Biotech last raise money?
Cleara Biotech's most recent round on record is a Seed, in Feb 2022.
What does Cleara Biotech do?
Cleara Biotech is a biotechnology company.
Where is Cleara Biotech headquartered?
Cleara Biotech is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like Cleara Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cleara Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cleara Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.